Sustainability Evaluation and Reporting by Pharmaceutical Companies

• Type: Poster in an International Conference
• Date: 2011

Authors

Teresa M. Mata (Author) FEUP; António A. Martins (Author) FEUP; Belmira Neto (Author) FEUP; M. Leonor Martins (Author) FEUP; C. A. Costa (Author) FEUP; R. L. R. Salcedo (Author) FEUP

Conference International

6th Dubrovnik Conference on Sustainable Development of Energy, Water and Environment Systems (SDEWES)

Dubrovnik, Croácia, 25-29 de Setembro de 2011

Scientific classification

FOS: Engineering and technology > Environmental engineering

CORDIS: Natural sciences > Environmental science > Natural resources management > Environmental protection

Other information

Abstract (EN): The awareness of sustainability as a main issue for companies’ performance has grown considerably over the last few years. This study aims to present the recent advances in this field by summarizing the key metric systems that have been proposed for the sustainability evaluation and reporting in the fine chemicals or pharmaceutical industry. Also, it describes how to perform a sustainability evaluation of pharmaceutical products throughout its supply chain. A framework for selecting sustainability indicators that takes into account all three sustainability dimensions (environmental, economic, and societal) is applied, given special attention to the identification of the significant potential environmental, economic, and social impacts associated with a pharmaceutical product’s value chain. A set of sustainability indicators is proposed for the quantitative sustainability evaluation of pharmaceutical products and processes, based on the relevant impacts identified for each supply chain stage.

Language: English

Type (Professor's evaluation): Scientific